Discover how naturopathic physician Bill Caradonna, R.Ph., ND, uses homeopathic trigger point and subcutaneous injections to ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Encouraging Results from Phase2a Trial of SGX945 in Behcet’s Disease ...

Hemlibra (emicizumab), the only treatment currently available for haemophilia A via the NHS that doesn't require an ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for treating adults with growth hormone deficiency (GHD).This ...

This study could potentially impact the stock performance of Regeneron Pharmaceuticals and Sanofi, as positive results may enhance investor sentiment and market valuation. The study’s focus on COPD, a ...

An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled ‘MagnetisMM-32’ ...

KalVista Pharmaceuticals faces a shrinking HAE market, tough competition, and launch uncertainty despite FDA approval. Read ...

While Rosie O’Donnell, 63, made a name for herself as a Broadway star and host of the Emmy-winning talk show The Rosie ...

Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone’s next phase of commercial execution ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.